Back to Agenda
Panel Discussion
Session Chair(s)
Fusashi Ishikawa, PHD, MSC
Associate Biopharmaceutics Research Fellow, Formulation R&D Laboratories, Sumitomo Dainippon Pharma Co., Ltd., Japan
Noriko Katori, PHD
Division of Drugs, National Institute of Health Sciences, Japan
Speaker(s)
Hiroyasu Ogata, PHD
Professor Emeritus, Meiji Pharmaceutical University, Japan
Chikako Yomota
Invited Researcher, National Institute of Health Sciences, Japan
Lawrence Yu, PHD
Director, Office of New Drug Products, OPQ, CDER, FDA, United States
Susana Almeida
Senior Director of European Operations, Inflamax Research Inc., Portugal
Yutaka Takahashi
Senior Manager, Pharmaceutical Planning & Control, Astellas Pharma Inc., Japan
Shinya Suzuki
Director, Planning & Administration Group,Technology Research & Development Mgmt, Sumitomo Dainippon Pharma Co., Ltd., Japan
Noriyuki Muranushi, PHD
Associate Director, Formulation R&D Center, CMC R&D Division, Shionogi & Co., Ltd., Japan
Hiroko Shibata
Senior Researcher, Division of Drugs, National Institute of Health Sciences, Japan
Have an account?